Bio-Rad
Brochure Describes Process to Concentrate and Enrich Low-and
Medium-Abundance Proteins
HERCULES,
Calif., February 1, 2008 – Bio-Rad
Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and
distributor of life science research and clinical diagnostic products, announced
today the availability of a six-page brochure (bulletin 5635) that described the
process used by its ProteoMiner® protein enrichment technology to
concentrate and enrich low- and medium-abundance proteins that are undetectable
through traditional methods.
The
brochure provides a side-by-side comparison of the ProteoMiner protein
enrichment kit with an Agilent MARS-14 column and provides:
·
A description
of the enrichment process
·
How it can
enhance both 2-D gel electrophoresis and SELDI analysis for biomarker discovery
·
Features
and benefits of the ProteoMiner system
·
A
description of the kits available
The
brochure is supported throughout by numerous graphs, tables, images and
figures.
About ProteoMiner
ProteoMiner
kits are compatible with a variety of sample types and can be used with all
major downstream protein analysis techniques including one- or two-dimensional
gel electrophoresis and mass spectrometry techniques. There are multiple kits
available providing flexibility to researchers; there are 2 kit sizes available
for processing 2 or 10 samples, and there is a Sequential Elution kit optimized
for SELDI experiments .
Availability
The
brochure is available from any Bio-Rad sales office or can be downloaded from
the Bio‑Rad web site by visiting www.bio-rad.com
The
ProteoMiner kits are available for immediate shipping upon receipt of an
order. For further information or to
place an order, please visit www.bio-rad.com/proteominer/
About Bio-Rad
Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) has remained at the center of
scientific discovery for more than 50 years manufacturing and distributing a
broad range of products for the life science research and clinical diagnostic
markets. The company is renowned worldwide among hospitals, universities, major
research institutions, as well as biotechnology and pharmaceutical companies
for its commitment to quality and customer service. Founded in 1952, Bio-Rad is
headquartered in Hercules, California, and serves more than 85,000 research and
industry customers worldwide through its global network of operations. The
company employs approximately 6,300 people
globally and had revenues of nearly $1.3 billion in 2006. For more information,
visit www.bio-rad.com.
This release contains certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995 and
Section 21E of the Securities Exchange Act of 1934. Forward-looking statements
generally can be identified by the use of forward-looking terminology such as,
“believe,” “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or
similar expressions or the negative of those terms or expressions. Such
statements involve risks and uncertainties, which could cause actual results to
vary materially from those expressed in or indicated by the forward-looking
statements. For further information regarding the Company's risks and
uncertainties, please refer to the “Risk Factors” in the Company’s public
reports filed with the Securities and Exchange Commission, including the Company’s
Annual Report on Form 10-K for the fiscal year ended December 31, 2006, as
updated by subsequent Quarterly Reports on Form 10-Q and Current Reports on
Form 8-K. The Company cautions you not to place undue reliance on
forward-looking statements, which reflect an analysis only and speak only as of
the date hereof. Bio-Rad Laboratories,
Inc. disclaims any obligation to update these forward-looking statements.
NOTE TO THE EDITOR:
For an html link to this news please
visit the following URL: http://www.alchymiacomm.com/NewsReleasesPhotography.htm
Sales information may be obtained by
calling a Bio-Rad sales office. Please do NOT use editor contact or corporate
telephone numbers.
Information in this release applies
specifically to products available in the United States. Product availability
and specifications may vary in non‑U.S. markets.
If you choose to review this item, your readers will receive the quickest response to their inquiries by e‑mailing them to lsg.orders.us@bio-rad.com or by calling 1-800-424-6723.
For more
information contact:
Kate Smith
Bio-Rad Laboratories, Inc.
510-724-5307
Doug Forsyth
Alchymia
Communications® LLC
541-482-8744